Identified a novel cellular pathway of gap junction internalization and degradation in the failing heart, offering potential therapeutic targets.
May guide future HF therapies; leaves open clinical relevance pending human validation.
Our data demonstrate a previously unrecognized pathway of gap junction internalization and degradation in the heart and identify a cellular pathway with potential therapeutic implications.
No takes yet. Share an insight, caveat, or question.
Hesketh et al. (2010) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: